A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
Item 1. Business Xtant Medical Holdings, Inc. is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Our products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. We promote our products in the United States through independent distributors and stocking agents, supported by direct employees. We have an extensive sales channel of independent commissioned agents and stocking distributors in the United States representing some or all of our products. We also maintain a national accounts program to enable our agents to gain access to integrated delivery network (“IDNs”) hospitals and through group purchasing organizations (“GPOs”).
| Metric | TTM | FY2024 | FY2023 | FY2022 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|
| Revenue | 130M | 117M | 91M | 58M | 83M | 90M |
| Net Income | -107K | -16M | 660K | -8.5M | -52M | -19M |
| EPS | $-0.01 | $-0.12 | $0.01 | $-0.09 | $-34.76 | $-18.46 |
| Free Cash Flow | 1.4M | -16M | -11M | -7.1M | -2.2M | -20M |
| ROIC | -1.9% | -25.3% | 1.0% | -19.3% | -28.3% | -4.1% |
| Gross Margin | 64.0% | 58.2% | 60.8% | 55.4% | 60.6% | 69.2% |
| Debt/Equity | 0.35 | 0.51 | 0.33 | 0.35 | -0.01 | -0.12 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | 4.5M | -12M | -10M | -6.8M | -38M | -7.5M |
| Operating Margin | 3.4% | -10.3% | -11.1% | -11.7% | -45.8% | -8.4% |
| ROE | -0.2% | -34.9% | 1.3% | -24.8% | - | - |
| Shares Outstanding | 140M | 137M | 66M | 94M | 13M | 13M |
Xtant Medical Holdings, Inc. passes 1 of 9 quality checks, indicating weak fundamentals.
The company's 5-year average gross margin is 60.8%. At current prices, the estimated annualized return to fair value is -14.4%.
Xtant Medical Holdings, Inc. (XTNT) has a 5-year average return on invested capital (ROIC) of -15.2%. This is below average and may indicate limited pricing power.
Xtant Medical Holdings, Inc. (XTNT) has a market capitalization of $71M. It is classified as a small-cap stock.
Xtant Medical Holdings, Inc. (XTNT) does not currently pay a regular dividend.
Xtant Medical Holdings, Inc. (XTNT) operates in the Surgical & Medical Instruments & Apparatus industry, within the Healthcare sector.
Xtant Medical Holdings, Inc. (XTNT) reported annual revenue of $117 million in its most recent fiscal year, based on SEC EDGAR filings.
Xtant Medical Holdings, Inc. (XTNT) has a net profit margin of -14.0%. The company is currently unprofitable.
Xtant Medical Holdings, Inc. (XTNT) generated $-16 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
Xtant Medical Holdings, Inc. (XTNT) has a debt-to-equity ratio of 0.51. This indicates moderate leverage.
Xtant Medical Holdings, Inc. (XTNT) reported earnings per share (EPS) of $-0.12 in its most recent fiscal year.
Xtant Medical Holdings, Inc. (XTNT) has a return on equity (ROE) of -34.9%. A negative ROE may indicate losses or negative equity.
Xtant Medical Holdings, Inc. (XTNT) has a 5-year average gross margin of 60.8%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 9 years of financial data for Xtant Medical Holdings, Inc. (XTNT), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
Xtant Medical Holdings, Inc. (XTNT) has a book value per share of $0.31, based on its most recent annual SEC filing.